Hennion & Walsh Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-124,483	Closed	-$8.48M	–	823
2022 Q3	$8.48M	Buy	124,483 +1,068	+0.9%	+$58.9K	0.56%	34
2022 Q2	$3.94M	Sell	123,415 -7,936	-6%	-$232K	0.24%	106
2022 Q1	$4.55M	Buy	131,351 +10,385	+9%	+$310K	0.24%	107
2021 Q4	$3.54M	Sell	120,966 -6,079	-5%	-$188K	0.17%	165
2021 Q3	$3.24M	Buy	127,045 +5,788	+5%	+$170K	0.17%	174
2021 Q2	$4.25M	Buy	121,257 +7,627	+7%	+$298K	0.23%	112
2021 Q1	$4.63M	Buy	+113,630	New	+$5.22M	0.28%	93

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hennion & Walsh Asset Management's GBT Position: Q4 2022 in Review

Hennion & Walsh Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 124,483 shares — an estimated $8.48M sold.

Hennion & Walsh Asset Management first reported a position in GBT in Q1 2021 and held it in 7 quarters. The position peaked at $8.48M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Hennion & Walsh Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Hennion & Walsh Asset Management sold 124,483 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $8.48M.
Hennion & Walsh Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2021 and held it in 7 quarters.
Hennion & Walsh Asset Management's Global Blood Therapeutics, Inc. position peaked at $8.48M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.